Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 19% below Graham Number — thin margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- ROE of 5.6% — below-average profitability
- Revenue growing at 1,319% annually
Hyperion DeFi, Inc. - Common Stock (HYPD) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $53 million . Key value metrics: P/E ratio 16.1, P/B ratio 0.91, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Hyperion DeFi, Inc. - Common Stock — Fundamental Analysis Summary
Hyperion DeFi, Inc. - Common Stock (HYPD) is trading 19% below its Graham Number of $4.34, offering a thin margin of safety. The stock carries a reasonable trailing P/E ratio of 16.1x.
On financial health, HYPD shows a moderate Piotroski F-Score of 4/9, and modest return on equity of 5.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.17.
StockPik's composite Value Score for HYPD is 80/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
HYPD reports a high gross margin of 76.5% (sector average: 39.4%) and a strong operating margin of 315.4%.
HYPD shows revenue growing at 1,319% year-over-year, with earnings growing at 9%.